Hong Kong
2 Vaccines Approved for Use in Hong Kong
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Inactivated
6 in Clinical Trials in Hong Kong
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
42 trials in 10 countries
DNA
The University of Hong Kong
SARS-CoV-2 DNA Vaccine
Replicating Viral Vector
The University of Hong Kong
DelNS1-nCoV-RBD LAIV
Inactivated
Sinovac Biotech (Hong Kong) Limited